Coordinated RNA sequencing, validation, and protein interaction analyses are planned, focusing on the duodenum of CRISPR-derived Fgf10 knockout mice with and without duodenal atresia, as well as additional wildtype controls. The gene discussed is FGF10; the disease is duodenal atresia.